Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, revenue was INR 0.09 million compared to INR 0.226 million a year ago. Net loss was INR 0.628 million compared to INR 0.375 million a year ago. Basic loss per share from continuing operations was INR 0.05 compared to INR 0.03 a year ago.